Therapy Areas: Infectious Diseases
First Light Diagnostics adds new member to international clinical advisory board
14 November 2019 -

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, announced yesterday that it has added Melvin P Weinstein, MD to its international clinical advisory board.

Dr Weinstein is the professor of Medicine and Pathology & Laboratory Medicine at Rutgers Robert Wood Johnson Medical School and is a fellow of the Infectious Disease Society of America, the American Academy of Microbiology and the American College of Physicians. He is presently the chair of the CLSI Subcommittee on Antimicrobial Susceptibility Testing.

David Macdonald, CEO of First Light Diagnostics, said, 'Dr Weinstein is a recognised expert in infectious disease and antimicrobial susceptibility testing (AST). We look forward to incorporating his valuable insights while implementing rapid phenotypic culture-free AST applications in the clinical laboratory, as an important member of our Clinical Advisory Board. Use of these applications will save lives, reduce healthcare cost and reduce the inappropriate use of antibiotics, which is driving the accelerating trend toward antimicrobial resistance.'

Login
Username:

Password: